AbbVie continues to be top of the TV drug ad spenders as its immunology blockbuster Skyrizi dominates this year’s iSpot roundup. After taking the top spot again last month, the Big Pharma is running ...
Skyrizi finished atop the Rx and over-the-counter (OTC) pharma brand ad rankings in August, according to data released by iSpot.tv on Wednesday afternoon. Skyrizi generated an impressions share of ...
AbbVie ABBV delivered encouraging second-quarter 2025 results last week, sending a clear message — it is effectively managing its post-Humira transition. The stronger-than-expected sales of newer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback